» Articles » PMID: 34961892

Tissue Engineering of Canine Cartilage from Surgically Debrided Osteochondritis Dissecans Fragments

Overview
Journal Ann Biomed Eng
Date 2021 Dec 28
PMID 34961892
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

This study in dogs explored the feasibility of using cartilage fragments removed and discarded during routine palliative surgery for osteochondritis dissecans (OCD) as a source of primary chondrocytes for scaffold-free cartilage tissue-engineering. Primary chondrocytes were obtained from three OCD donors and one age-matched healthy articular cartilage (HAC) donor. After monolayer expansion of primary cells, a three-dimensional spherical suspension culture was implemented. Following this stage, cells were seeded at a high density into custom-made agarose molds that allowed for size and shape-specific constructs to be generated via a method of cellular self-assembling in a scaffold-free environment. Fifty-eight neocartilage constructs were tissue-engineered using this methodology. Neocartilage constructs and native cartilage from shoulder joint were subjected to histological, mechanical, and biochemical testing. OCD and HAC chondrocytes-sourced constructs had uniformly flat morphology and histology consistent with cartilage tissue. Constructs sourced from OCD chondrocytes were 1.5-times (32%) stiffer in compression and 1.3 times (23%) stronger in tension than constructs sourced from HAC chondrocytes and only 8.7-times (81%) less stiff in tension than native tissue. Constructs from both cell sources consistently had lower collagen content than native tissue (22.9%/dry weight [DW] for OCD and 4.1%/DW for HAC vs. 51.1%/DW native tissue). To improve the collagen content and mechanical properties of neocartilage, biological and mechanical stimuli, and thyroid hormone (tri-iodothyronine) were applied to the chondrocytes during the self-assembling stage in two separate studies. A 2.6-fold (62%) increase in compressive stiffness was detected with supplementation of biological stimuli alone and 5-fold (81%) increase with combined biological and mechanical stimuli at 20% strain. Application of thyroid hormone improved collagen content (1.7-times, 33%), tensile strength (1.8-times, 43%), and stiffness (1.3-times, 21%) of constructs, relative to untreated controls. Collectively, these data suggest that OCD chondrocytes can serve as a reliable cell source for cartilage tissue-engineering and that canine chondrocytes respond favorably to biological and mechanical stimuli that have been shown effective in chondrocytes from other animal species, including humans.

Citing Articles

Recent advancements in cartilage tissue engineering innovation and translation.

Nordberg R, Bielajew B, Takahashi T, Dai S, Hu J, Athanasiou K Nat Rev Rheumatol. 2024; 20(6):323-346.

PMID: 38740860 PMC: 11524031. DOI: 10.1038/s41584-024-01118-4.


Novel advances in strategies and applications of artificial articular cartilage.

Chen Y, Zhang C, Zhang S, Qi H, Zhang D, Li Y Front Bioeng Biotechnol. 2022; 10:987999.

PMID: 36072291 PMC: 9441570. DOI: 10.3389/fbioe.2022.987999.

References
1.
Allen K, Athanasiou K . Viscoelastic characterization of the porcine temporomandibular joint disc under unconfined compression. J Biomech. 2005; 39(2):312-22. DOI: 10.1016/j.jbiomech.2004.11.012. View

2.
Goldberg A, Lee D, Bader D, Bentley G . Autologous chondrocyte implantation. Culture in a TGF-beta-containing medium enhances the re-expression of a chondrocytic phenotype in passaged human chondrocytes in pellet culture. J Bone Joint Surg Br. 2005; 87(1):128-34. View

3.
Arufe M, de la Fuente A, Fuentes I, de Toro F, Blanco F . Chondrogenic potential of subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial membranes. J Cell Biochem. 2010; 111(4):834-45. DOI: 10.1002/jcb.22768. View

4.
Ronziere M, Perrier E, Mallein-Gerin F, Freyria A . Chondrogenic potential of bone marrow- and adipose tissue-derived adult human mesenchymal stem cells. Biomed Mater Eng. 2010; 20(3):145-58. DOI: 10.3233/BME-2010-0626. View

5.
Rainaldi G, Pinto B, Piras A, Vatteroni L, Simi S, Citti L . Reduction of proliferative heterogeneity of CHEF18 Chinese hamster cell line during the progression toward tumorigenicity. In Vitro Cell Dev Biol. 1991; 27A(12):949-52. DOI: 10.1007/BF02631122. View